Figure S1. The flow diagram for inclusion of patients. This flow diagram shows the process of inclusion of patients. Figure S2. An example of chemotherapy protocol. This picture shows an example of chemotherapy protocol with 9 courses of adjuvant chemotherapy, patients included in our study received 9 or more adjuvant chemotherapy courses. Figure S3. An example of measuring tumor volumes (TVS) and extraosseous tumor volumes (ETVS). A. Measurement of tumor length from coronary section. B. Measurement of tumor width and depth from transverse section. C. Measurement of intraosseous tumor length from coronary section. D. Measurement of intraosseous tumor width and depth from transverse section. (DOCX 531âkb
Additional file 1: Fig. S1. Tumor volume of different treatment groups on Day 10. SPESN38-5 by IV wa...
Appendix S1. Search strategy. Figure S2. PRISMA flow chart. Figure S3. Forest plots of α, β and α/β,...
Figure S1. Examples of assays used to assess potency of CFU-F clonal cultures at P1. Left panel: Exa...
Figure S1. Characteristics of patients whose tumor samples are included in tissue micro-array (TMA)....
The league table of the network for the progression-free survival estimates the treatments according...
Table S1. Significant pathways of the purple module. Table S2. Significant pathways of the brown mod...
Figure S1. Metabolic description of the tumors using [18F]FDG and Na[18F]F. Three cases of tumors ob...
Additional file 1: Supp. Table 1. Breast cancer type. Supp. Table 2. Tumor and Lymph node distributi...
Figure S1. a Cancer-associated fibroblasts (CAFs) culture-conditioned media used with MKN-45 and MKN...
Figure S1. Postbaseline time point assessments for tumor response by study for patients with ≥ 1 eva...
Table S1. Selected clinicopathologic features of the patients included in this study according to th...
Subgroup analyses of OS with respect to patient characteristics. OS was compared in each subgroup wi...
Figure S2. CYR61 controls osteosarcoma cell phenotype in vitro. (A) Morphology of K7 M2 and U2OS ost...
Figure S3: Forest plot of OS (a) and PFS (b) with doxorubicin alone vs experimental chemotherapy. (P...
Additional file 3: Figure S3: Funnel plots of the rate of radiographic progression. Subgroup analysi...
Additional file 1: Fig. S1. Tumor volume of different treatment groups on Day 10. SPESN38-5 by IV wa...
Appendix S1. Search strategy. Figure S2. PRISMA flow chart. Figure S3. Forest plots of α, β and α/β,...
Figure S1. Examples of assays used to assess potency of CFU-F clonal cultures at P1. Left panel: Exa...
Figure S1. Characteristics of patients whose tumor samples are included in tissue micro-array (TMA)....
The league table of the network for the progression-free survival estimates the treatments according...
Table S1. Significant pathways of the purple module. Table S2. Significant pathways of the brown mod...
Figure S1. Metabolic description of the tumors using [18F]FDG and Na[18F]F. Three cases of tumors ob...
Additional file 1: Supp. Table 1. Breast cancer type. Supp. Table 2. Tumor and Lymph node distributi...
Figure S1. a Cancer-associated fibroblasts (CAFs) culture-conditioned media used with MKN-45 and MKN...
Figure S1. Postbaseline time point assessments for tumor response by study for patients with ≥ 1 eva...
Table S1. Selected clinicopathologic features of the patients included in this study according to th...
Subgroup analyses of OS with respect to patient characteristics. OS was compared in each subgroup wi...
Figure S2. CYR61 controls osteosarcoma cell phenotype in vitro. (A) Morphology of K7 M2 and U2OS ost...
Figure S3: Forest plot of OS (a) and PFS (b) with doxorubicin alone vs experimental chemotherapy. (P...
Additional file 3: Figure S3: Funnel plots of the rate of radiographic progression. Subgroup analysi...
Additional file 1: Fig. S1. Tumor volume of different treatment groups on Day 10. SPESN38-5 by IV wa...
Appendix S1. Search strategy. Figure S2. PRISMA flow chart. Figure S3. Forest plots of α, β and α/β,...
Figure S1. Examples of assays used to assess potency of CFU-F clonal cultures at P1. Left panel: Exa...